Jose Manuel Valdivielso Revilla

Bozic M; Méndez-Barbero N; Gutiérrez-Muñoz C; Betriu A; Egido J; Fernández E; Martín-Ventura JL; Valdivielso JM; Blanco-Colio LM

Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease

Atherosclerosis 270 13-20. 01/03/2018.

[doi:10.1016/j.atherosclerosis.2018.01.011]

Bermudez-Lopez, M; Betriu À; Valdivielso, JM; Bretones Del Pino T; Arroyo, D; Fernandez, E

Beyond the traditional lipid parameters in chronic kidney disease

Nefrologia 38 109-113. 01/03/2018.

[doi:10.1016/j.nefro.2017.09.008]

Rayego-Mateos, S; Rodrigues-Diez, R; Morgado-Pascual, JL; Valentijn, F; Valdivielso, JM; Goldschmeding, R; Ruiz-Ortega, M

Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage

Mediators of Inflammation 2018 8739473-8739473. 01/01/2018.

[doi:10.1155/2018/8739473]

Borràs Sans M; Pérez-Fontán M; Martinez-Alonso M; Bajo A; Betriu À; Valdivielso JM; Fernández E

The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease

PLOS ONE 12 -. 02/11/2017.

[doi:10.1371/journal.pone.0186921]

Abajo M; Betriu À; Arroyo D; Gracia M; Del Pino MD; Martínez I; Valdivielso JM; Fernández E

Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease: the NEFRONA study

NEPHROLOGY DIALYSIS TRANSPLANTATION 32 1882-1891. 01/11/2017.

[doi:10.1093/ndt/gfw306]

Valdivielso JM; Betriu A; Martinez-Alonso M; Arroyo D; Bermudez-Lopez M; Fernandez E

Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound

PLOS ONE 12 -. 18/10/2017.

[doi:10.1371/journal.pone.0186665]

Khan AUH; Allende-Vega, N; Gitenay, D; Gerbal-Chaloin, S; Gondeau, C; Vo, DN; Belkahla, S; Orecchioni, S; Talarico, G; Bertolini, F; Bozic, M; Valdivielso, JM; Bejjani, F; Jariel, I; Lopez-Mejia, IC; Fajas, L; Lecellier, CH; Hernandez, J; Daujat, M; Villalba, M

The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway

SCIENTIFIC REPORTS 7 10654-10654. 06/09/2017.

[doi:10.1038/s41598-017-10339-5]

Bermudez-Lopez, M; Arroyo, D; Betriu À; Masana, L; Fernandez, E; Valdivielso, JM

New perspectives on CKD-induced dyslipidemia

Expert Opinion On Therapeutic Targets 21 967-976. 28/08/2017.

[doi:10.1080/14728222.2017.1369961]

Gracia, M; Betriu, A; Martinez, M; Arroyo, D; Abajo, M; Fernandez, E; Valdivielso, JM

KLOTHO GENE POLYMORPHISMS ARE ASSOCIATED WITH PROGRESSION OF ATHEROMATOSIS IN PATIENTS WITH CKD. RESULTS OF TWO YEARS FOLLOW-UP OF THE NEFRONA COHORT

NEPHROLOGY DIALYSIS TRANSPLANTATION 32 -. 01/05/2017.

Fernandez-Laso, V; Mendez-Barbero, N; Valdivielso, JM; Betriu, A; Fernandez, E; Egido, J; Martin-Ventura, JL; Blanco-Colio, LM

Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease

Atherosclerosis 260 130-137. 01/05/2017.

[doi:10.1016/j.atherosclerosis.2017.03.043]

Arroyo D; Betriu A; Valls J; Gorriz JL; Pallares V; Abajo M; Gracia M; Valdivielso JM; Fernandez E

Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study

NEPHROLOGY DIALYSIS TRANSPLANTATION 32 513-520. 01/03/2017.

[doi:10.1093/ndt/gfw039]

Torremade, N; Bozic, M; Goltzman, D; Fernandez, E; Valdivielso, JM

Effects of the Administration of 25(OH) Vitamin D3 in an Experimental Model of Chronic Kidney Disease in Animals Null for 1-Alpha-Hydroxylase

PLOS ONE 12 -. 20/01/2017.

[doi:10.1371/journal.pone.0170654]